Latest Updates
-
Horoscope for Today April 29, 2026 - Calm Focus & Steady Progress -
Maharashtra Day 2026: Why The State Of Bombay Split Into Two And How The Day Is Marked With Celebrations -
Vegetable Kurma Recipe: Experience South Indian Authentic Taste -
Home Cooling Tips Without An Air Conditioner This Summer – 6 Decor Solutions That Do The Trick! -
Sweet Spicy Street Style Honey Chilli Potato Recipe -
Beauty Hacks 101: 5 Easy Ways To Use Mango For Quick Summer Skin Fixes At Home -
Two Teachers Die On Census Duty In Odisha, Heatstroke Suspected: Why Summers Are Getting Harder To Survive -
Veg Fried Rice Recipe: Master the Wok Toss Restaurant Trick -
Samantha Ruth Prabhu Birthday Special: 7 Outfits That Redefined ‘The Family Man 2’ Star’s Power Dressing -
Hidden Signs Of Insulin Resistance: What Your Body Is Trying To Tell You
Compound That Can Potentially Ease COVID-19 Symptoms Identified
Scientists have identified a compound that shows potential in easing the symptoms of COVID-19 infection in laboratories and animals.

The team, from the US Department of Energy's Pacific Northwest National Laboratory (PNNL) and the University of North Carolina (UNC), studied the virus that causes Middle East Respiratory Syndrome, which is caused by a coronavirus.
MERS is much less common, but much more lethal, than COVID-19.
The study, published in the journal mBio, analysed tens of thousands of measurements in the laboratory of proteins, molecular messengers and other signals that occur after infection.
The researchers pinpointed a molecular process, part of the body's quality-control machinery, that plays a central role in causing damage from a coronavirus infection.
They then searched a vast database of compounds and identified one known as AMG PERK 44 that put a halt to virus reproduction in human tissue in the laboratory.
The team also found the compound has a strong effect in mice infected with the virus. The compound boosted lung function and reduced lung damage and weight loss in the mice, particularly in male mice, according to the researchers.
"Studies like this help us learn more about how deadly respiratory viruses operate, how they do what they do, why they attack certain parts of the lung and not others," said virologist Amy Sims, one of two first coauthors of the paper from PNNL, along with Hugh Mitchell.
The scientists noted that it is far too soon to know whether the compound could help patients as it is not currently used as a drug. The results of the study are most useful as part of a broader effort to learn more about respiratory diseases, they added.
"Coronavirus infections cause complex disease phenotypes, and new strategies are needed to disentangle which host pathways are contributing to the development of severe, life-threatening outcomes," Ralph Baric from UNC added.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications